Medicare Enrolled
Dr. Suraj Kamat, MD
Cardiovascular Disease · Alice, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kamat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kamat? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kamat
Dr. Suraj Kamat is a cardiovascular disease in Alice, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kamat performed 11,100 Medicare services across 2,222 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kamat received a total of $47,899 from 45 pharmaceutical and/or device companies across 689 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kamat is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $47,899 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,100
Medicare services
Top 2% in TX for cardiovascular disease
2,222
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~555 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 6,178 | $0 | $1 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 1,664 | $0 | $20 |
| Telehealth originating site facility fee | 648 | $20 | $35 |
| Remote pacemaker/defibrillator monitoring, 90 days | 309 | $15 | $33 |
| Remote pacemaker monitoring, 90 days | 276 | $21 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 249 | $8 | $15 |
| Office visit, established patient (30-39 min) | 246 | $82 | $188 |
| Electrocardiogram (EKG), 12-lead | 118 | $10 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 97 | $37 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 77 | $4 | $9 |
| EKG interpretation and report | 77 | $5 | $13 |
| Echocardiogram, transthoracic | 73 | $81 | $192 |
| Programming of dual lead pacemaker system | 69 | $55 | $121 |
| Ultrasonic guidance for blood vessel access | 66 | $30 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 64 | $271 | $552 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 64 | $20 | $95 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 63 | $80 | $278 |
| Hospital follow-up visit, low complexity | 62 | $38 | $56 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 52 | $17 | $34 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 48 | $63 | $145 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 39 | $715 | $1,421 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 39 | $133 | $250 |
| Cardiac catheterization | 36 | $163 | $418 |
| Office visit, established patient, complex (40-54 min) | 36 | $114 | $265 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 33 | $27 | $100 |
| Coronary stent placement | 31 | $371 | $834 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $49 | $111 |
| Hospital follow-up visit, moderate complexity | 28 | $62 | $103 |
| Initial hospital admission, high complexity | 27 | $136 | $287 |
| Ultrasound of leg arteries or artery grafts | 26 | $148 | $305 |
| Review by radiologist of arm or leg artery image | 24 | $104 | $216 |
| Insertion of stent in vein with review by radiologist, initial vein | 23 | $2,628 | $5,207 |
| Review by radiologist of major lower body vein image | 23 | $87 | $168 |
| Removal of plaque in artery of leg, initial vessel | 22 | $6,065 | $13,172 |
| Ultrasound of both sides of head and neck blood flow | 21 | $101 | $229 |
| Initial hospital admission, moderate complexity | 21 | $102 | $196 |
| Injection for x-ray imaging procedure into vein of arm or leg | 20 | $107 | $382 |
| Review by radiologist of both arms or legs arteries image | 20 | $114 | $240 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 17 | $94 | $231 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 16 | $431 | $935 |
| New patient office visit (30-44 min) | 16 | $63 | $164 |
| Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist | 15 | $720 | $2,058 |
| Removal of plaque in arteries of leg | 15 | $4,784 | $13,067 |
| Removal of plaque and insertion of stents in arteries of leg | 12 | $8,023 | $16,932 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $179 | $476 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.0% high complexity
73.4% medium
18.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,899
Total received (2018-2024)
Avg $6,843/year across 7 years
Top 11% in TX for cardiovascular disease
45
Companies
689
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$28,522 (59.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,455 (28.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,922 (12.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$6,939
2023$26,188
2022$2,543
2021$7,212
2020$1,286
2019$2,416
2018$1,317
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$28,522
Cardiovascular Systems Inc.
$7,066
ABIOMED
$2,926
Medtronic Vascular, Inc.
$1,951
Medtronic, Inc.
$1,537
Janssen Pharmaceuticals, Inc
$1,142
BIOTRONIK INC.
$733
ShockWave Medical, Inc
$403
Bard Peripheral Vascular, Inc.
$312
Reflow Medical Inc
$302
Abbott Laboratories
$276
Novartis Pharmaceuticals Corporation
$273
PFIZER INC.
$271
Boston Scientific Corporation
$243
Merck Sharp & Dohme LLC
$199
Cook Medical LLC
$195
AstraZeneca Pharmaceuticals LP
$177
Shockwave Medical, Inc
$167
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$138
SANOFI-AVENTIS U.S. LLC
$95
Teleflex LLC
$90
BARD PERIPHERAL VASCULAR, INC.
$84
Merck Sharp & Dohme Corporation
$79
Philips Electronics North America Corporation
$70
Lundbeck LLC
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
Becton, Dickinson and Company
$62
Actelion Pharmaceuticals US, Inc.
$51
Impulse Dynamics (USA) Inc.
$44
Acist Medical Systems, Inc.
$39
Gilead Sciences, Inc.
$39
E.R. Squibb & Sons, L.L.C.
$34
Regeneron Healthcare Solutions, Inc.
$33
Inspire Medical Systems, Inc.
$33
Amarin Pharma Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$20
Esperion Therapeutics, Inc.
$19
Arbor Pharmaceuticals, Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$16
Amgen Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
CARDIVA MEDICAL, INC.
$14
VivaQuant Inc, dba Rhythm Express
$14
Maquet Cardiovascular U.S. Sales, L.L.C.
$12
Top 3 companies account for 80.4% of total payments
Associated products mentioned in payments ›
(6536) Phoenix · (6582) Visions 035 · ABRE · ADMIRAL XTREME · ADVANCE · ARROW · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · Abre · Admiral Xtreme · Aptus Heli-FX · Auryon Laser System 100-120 Vac · BOSENTAN TABLETS · BRILINTA · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CHOCOLATE PTA BALLOON CATHETER · COOK MEDICAL CATHETERS · COOK MEDICAL ZILVER PTX · COREVALVE EVOLUT R · Cook Medical Zilver PTX · CoreValve Evolut · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Diamondback Coronary · Diamondback Peripheral · Dragonfly OCT · DxTerity · ELIQUIS · ENDURANT IIS · ENTEER · ENTRESTO · ESPRIT · EUPHORA · EVERCROSS · EVERFLEX · EVERFLEX PROTG EVERFLEX · Edarbi · Endurant · Enteer · EverCross · Export · FARXIGA · FFRANGIO · FLIXENE · FORMULA 418 · General - Atherectomy · HAWKONE · HD-IVUS · HawkOne · IGT D Peripheral · IGT Devices Und · IN.PACT ADMIRAL · IN.PACT Admiral · INSPIRE · Impella · Integrity · JARDIANCE · LAUNCHER · LEQVIO · LUTONIX · Launcher · LifeStent Solo Vascular Stent · LifeStream · LifeVest · Livalo · Lutonix Drug Coated Balloon · Mitra Clip system · NANOCROSS ELITE · NC STORMER OTW · NEXLETOL · NITREX · NORTHERA · ONPATTRO · ONYX FRONTIER · OPSUMIT · Optimizer · Optimizer Smart System · Orsiro Mission · PACIFIC XTREME · PK Papyrus · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Passeo-18 · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · ProVia · Protege EverFlex · Pulsar-18 T3 · RELIANT · RESOLUTE ONYX · ROSEN · ReCross · Repatha · Resolute · Reveal LINQ · Rhythm Express · SENTRANT · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SPIDERFX · SUPERCROSS · SYMPLICITY G3 · Sentrant · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · SpiderFX · Sprinter · TELEMARK MICROCATHETER · TELESCOPE · TORCON NB · TOURGUIDE STEERABLE SHEATH · TRAILBLAZER · TURBOHAWK · Telescope · TourGuide · TurboHawk · UPTRAVI · VENOVO · VENTURE · VERQUVO · VIANCE · VISI-PRO · VYNDAQEL · Valiant Captivia · Vascepa · Vascular Lithotripsy · Venovo · Viance · Visi-Pro · WALLSTENT · XARELTO · Xience Sierra Coronary Stent System · ZILVER PTX · ZILVER VENA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Equivalent to $432 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
2
Per 100K population
5.1
County median income
$47,492
Nearest hospital
CHRISTUS SPOHN HOSPITAL ALICE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kamat is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (mixed engagement, top 11%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kamat experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Kamat performed 6,178 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kamat receive payments from pharmaceutical companies?
Yes. Dr. Kamat received a total of $47,899 from 45 companies across 689 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kamat's costs compare to other cardiovascular diseases in Alice?
Dr. Kamat's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kamat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Alice
Browse cardiovascular diseases in Alice ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc..
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology